Cargando…
Successful treatment of ulcerated pyoderma gangrenosum with baricitinib, a novel JAK inhibitor
Pyoderma gangrenosum manifests as an ulceration of the skin often associated with several systemic diseases. The diagnosis is usually made by exclusion criteria with suggestions made by clinical findings and histological features. It can occur any site but more common in the legs. Advances in transl...
Autores principales: | Scheinberg, Morton, Machado, Luis Antônio, M Castro, Luiz Guilherme, Ferreira, Sineida Berbert, Michalany, Nilceo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100614/ https://www.ncbi.nlm.nih.gov/pubmed/33997753 http://dx.doi.org/10.1016/j.jtauto.2021.100099 |
Ejemplares similares
-
Topical tofacitinib in treatment of alopecia areata
por: Ferreira, Sineida Berbert, et al.
Publicado: (2020) -
An excellent response to tofacitinib in a Brazilian adolescent patient with alopecia areata: A case report and a review of the literature
por: Berbert Ferreira, Rachel, et al.
Publicado: (2019) -
Atopic dermatitis: Tofacitinib, an option for refractory disease
por: Berbert Ferreira, Sineida, et al.
Publicado: (2020) -
Peripheral Ulcerative Keratitis with Pyoderma Gangrenosum
por: Imbernón-Moya, Adrián, et al.
Publicado: (2015) -
Pyoderma Gangrenosum: An Ulcer With Unorthodox Treatment
por: Baruah, Tridip Dutta, et al.
Publicado: (2021)